Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial

Marko Banović(University of Belgrade), Svetozar Putnik(University of Belgrade), Mark Da Costa(University Hospital Galway), Bernard Iung, Filip Casselman(Onze Lieve Vrouwziekenhuis Hospital), Milika Ašanin(University of Belgrade), Hrvoje Gašparović(University Hospital Centre Zagreb), Jozef Bartúnek(Onze Lieve Vrouwziekenhuis Hospital), Faisal Sharif(Ollscoil na Gaillimhe – University of Galway), Branko Beleslin(University of Belgrade), Milan Nedeljković(University of Belgrade), Petr Kala(Masaryk University), Ivana Nedeljković(University of Belgrade), Marc Vanderheyden(Onze Lieve Vrouwziekenhuis Hospital), Michael Pencina(Tufts Medical Center), Bojan Biočina(University Hospital Centre Zagreb), Martin Pěnička, Zlatibor Lončar, Peter Nemec(Masaryk University), Arsen Ristić, L. Labrousse(Hôpital Cardiologique du Haut-Lévêque), Guy Van Camp(Onze Lieve Vrouwziekenhuis Hospital), Jelena Marinković(University of Belgrade), Serge Nikolic(BioVentrix (United States)), Marek Deja(Medical University of Silesia)
American Heart Journal
February 8, 2016
Cited by 61


Related Papers